PTEN公司
PI3K/AKT/mTOR通路
轴突
张力素
再生(生物学)
生物
条件基因敲除
细胞生物学
蛋白激酶B
神经科学
信号转导
表型
遗传学
基因
作者
Kevin Kyungsuk Park,Kai Liu,Yang Hu,Patrice D. Smith,Chen Wang,Bin Cai,Bengang Xu,Lauren Connolly,Ioannis Kramvis,Mustafa Şahin,Zhigang He
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:2008-11-07
卷期号:322 (5903): 963-966
被引量:1409
标识
DOI:10.1126/science.1161566
摘要
The failure of axons to regenerate is a major obstacle for functional recovery after central nervous system (CNS) injury. Removing extracellular inhibitory molecules results in limited axon regeneration in vivo. To test for the role of intrinsic impediments to axon regrowth, we analyzed cell growth control genes using a virus-assisted in vivo conditional knockout approach. Deletion of PTEN (phosphatase and tensin homolog), a negative regulator of the mammalian target of rapamycin (mTOR) pathway, in adult retinal ganglion cells (RGCs) promotes robust axon regeneration after optic nerve injury. In wild-type adult mice, the mTOR activity was suppressed and new protein synthesis was impaired in axotomized RGCs, which may contribute to the regeneration failure. Reactivating this pathway by conditional knockout of tuberous sclerosis complex 1, another negative regulator of the mTOR pathway, also leads to axon regeneration. Thus, our results suggest the manipulation of intrinsic growth control pathways as a therapeutic approach to promote axon regeneration after CNS injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI